Texas Pediatric Cancer Drug Testing Core Seminar Series
The Texas Pediatric Cancer Drug Testing Core (TPC-DTC) will be hosting the virtual seminar series for those interested in preclinical evaluation of novel agents in xenograft mouse models of pediatric cancer.
The objective of the CPRIT-supported TPC-DTC is to provide reproducible high-quality in vivo data to guide pediatric clinical development of novel agents and combinations.
The TPC-DTC provides access to~400 PDX/CDX models of pediatric cancers as a resource.
Save the Dates for the Talks by:
